Attached files

file filename
S-1/A - FORM S-1/A - Clovis Oncology, Inc.d82988a4sv1za.htm
EX-1.1 - EX-1.1 - Clovis Oncology, Inc.d82988a4exv1w1.htm
EX-5.1 - EX-5.1 - Clovis Oncology, Inc.d82988a4exv5w1.htm
EX-3.1 - EX-3.1 - Clovis Oncology, Inc.d82988a4exv3w1.htm
EX-10.3 - EX-10.3 - Clovis Oncology, Inc.d82988a4exv10w3.htm
EX-10.5 - EX-10.5 - Clovis Oncology, Inc.d82988a4exv10w5.htm
EX-10.2 - EX-10.2 - Clovis Oncology, Inc.d82988a4exv10w2.htm
EX-10.7 - EX-10.7 - Clovis Oncology, Inc.d82988a4exv10w7.htm
EX-10.27 - EX-10.27 - Clovis Oncology, Inc.d82988a4exv10w27.htm
EX-10.29 - EX-10.29 - Clovis Oncology, Inc.d82988a4exv10w29.htm
EX-10.30 - EX-10.30 - Clovis Oncology, Inc.d82988a4exv10w30.htm
EX-10.28 - EX-10.28 - Clovis Oncology, Inc.d82988a4exv10w28.htm
EX-10.31 - EX-10.31 - Clovis Oncology, Inc.d82988a4exv10w31.htm
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated April 29, 2011 (except Notes 1, 2, 6, 7, 8 and 11, as to which the date is October 28, 2011) in Amendment No. 3 to the Registration Statement (Form S-1 No. 333-175080) and related Prospectus of Clovis Oncology, Inc. for the registration of shares of its common stock.
/s/ Ernst & Young LLP
Denver, Colorado
October 28, 2011